United States · Platforms & data · MarketBeat

Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits

Published by MarketBeat · United States 1 h ago

Edwards Lifesciences (NYSE:EW) highlighted new clinical data for its transcatheter tricuspid repair and transcatheter aortic valve replacement programs, including results from the…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits

Share

Also worth reading

Fabrinet (FN) Q1 2027 Earnings Call Transcript

Angel Oak Financial Strategies Income Term declares $0.115 dividend

Adani Group seeks $1.5 bln loan for data center expansion- Economic Times

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows

Theta Gold Mines Reports Expiry of 12.6 Million Options